GGrantIndex
Sort

78,016 grants matching breast cancer

Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system

$601,825
Daniela Annenelie Bota · University Of California-Irvine · R01 · FY2025 · CA

COMPLETE VARIANT PROFILING OF ALL KNOWN BREAST CANCER GENES

$601,706
Mary-Claire King · University Of Washington · R01 · FY2014 · CA

Fecal microbial transplantation for chemotherapy behavioral side effects

$601,697
Leah M Pyter · Ohio State University · R01 · FY2025 · CA

PHASE IIB TRIAL OF NEOADJUVANT ORAL TAMOXIFEN VERSUS TRANSDERMAL 4-HYDROXYTAMOXIFEN IN WOMEN WITH DCIS OF THE BREAST

$601,680
Seema Khan · Northwestern University At Chicago · N01 · FY2019 · CA

Project 3: Enhanced Sensitivity of Tumors to Proton Beam Therapy: Mechanisms and Biomarkers.

$601,652
David R Grosshans · Massachusetts General Hospital · P01 · FY2022 · CA

Enabling effective anti-tumor immunity from targeted antibodies through dual innate and adaptive immune checkpoint blockade in non-immunogenic cancers

$601,640
Zachary Conrad Hartman · Duke University · R01 · FY2022 · CA

SMALL MOLECULE INHIBITORS OF TYROSINE PHOSPHATASE PTP4A3 A NOVEL THERAPEUTIC PARADIGM FOR TREATING BREAST CANCER

$601,632
University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2018 · Department of the Army

Satisfaction of Search in Breast Cancer Detection

$601,585
Claudia R Mello-Thoms · University Of Iowa · R01 · FY2023 · CA

Validation and Translation of MasSpec Pen Technology for Intraoperative Evaluation of Non-small Cell Lung Cancer

$601,550
Livia Schiavinato Eberlin · Baylor College Of Medicine · R01 · FY2023 · CA

Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis

$601,506
Heide L Ford · University Of Colorado Denver · R01 · FY2022 · CA

Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis

$601,506
Heide L Ford · University Of Colorado Denver · R01 · FY2023 · CA

Towards a Transdisciplinary Understanding of Breast Cancer Survival Disparities

$601,478
Deirdre Hill · University Of New Mexico · R01 · FY2010 · CA

Dual Modality X-ray Luminescence CT for in vivo Cancer Imaging

$601,430
Lei Xing · Stanford University · R01 · FY2020 · CA

Molecular Targets for Cancer Detection and Treatment

$601,428
William George Nelson · Johns Hopkins University · T32 · FY2013 · CA

Small-molecule degraders of BET proteins

$601,424
Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2019 · CA

Genetic Epidemiology of Cancer

$601,408
Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2015 · HG

NCI Community Oncology Research Program (NCORP) Community Sites

$601,401
Albert Denittis · Lankenau Institute For Medical Research · UG1 · FY2017 · CA

UNIVERSITY OF ROCHESTER--CCOP RESEARCH BASE

$601,397
University Of Rochester · U10 · FY2000 · CA

NRF2 suppression of inflammatory signaling and its role in tumor progression

$601,353
James V Alvarez · Fred Hutchinson Cancer Center · R01 · FY2025 · CA

Virtual Clinical Trials: Simulation of Digital Breast Tomosynthesis Screening

$601,308
Andrew Douglas Arnold Maidment · University Of Pennsylvania · R01 · FY2012 · CA

Philadelphia Breast Cancer Family Registry

$601,234
Mary Beryl Daly · Fox Chase Cancer Center · U01 · FY2009 · CA

Leveraging tumor registries and pathology specimens to facilitate genetic testing and traceback for ovarian cancer

$601,233
Jessica Ezzell Hunter · Kaiser Foundation Research Institute · U01 · FY2022 · CA

Adhesive crosstalk in collective tumor cell invasion

$601,233
Denis Wirtz · Johns Hopkins University · U54 · FY2020 · CA

Breast Cancer PARP PET Imaging AIP to Support FDA Approval & Commercialization

$601,217
David A Mankoff · University Of Pennsylvania · R01 · FY2022 · CA

Development of an Integrated Risk Prediction Model of Taxane-induced Peripheral Neuropathy

$601,172
Daniel Louis Hertz · University Of Michigan At Ann Arbor · R37 · FY2023 · CA